Turn this list into pipeline.
Pharmaceutical Companies in Glasgow: 100+ Active Firms (2026)
Pharmaceutical companies in Glasgow research, manufacture and distribute medicines under MHRA oversight across the city-region.
Buying centres tend to sit in medical, quality, regulatory affairs, market access and supply-chain teams rather than a central technology or procurement function. Customer targets range from public-sector health buyers and wholesale distributors to medicine developers preparing evidence packages, with engagements shaped by licence scope, validation burden and audit readiness. Sales cycles are usually relationship-led and documentation-heavy: a small manufacturing or distribution contract can still require site due diligence, qualified-person oversight, pharmacovigilance arrangements and evidence that good manufacturing practice or good distribution practice is embedded in routine operations.
Read more
Glasgow has 151 actively trading pharmaceutical companies, making the local cohort sizeable enough to include specialist distributors, manufacturing-adjacent operators and research-led businesses, rather than only advisory or dormant entities. Reported headcount across the cohort is 474 people, so the employment footprint is visible but still relatively concentrated. The balance implied by the company mix is practical: many firms appear to sit close to regulated supply, quality assurance and market-access preparation, while a smaller group reaches the turnover scale associated with licensed production or wholesale distribution contracts.
Human medicines sit under MHRA control, with licence requirements following the activity undertaken. Organisations that make, assemble or import medicines need a manufacturer’s licence, good manufacturing practice compliance and regular site inspection. Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance. Marketing authorisation, pharmacovigilance and evidence for public reimbursement add further checkpoints before a medicine can move from regulated product to routine clinical use. ABPI remains the main trade body reference point for research-based pharmaceutical businesses, but the operational burden falls through licences, inspections and accountable quality systems.
Commercial progression appears likely to favour operators that can combine regulated handling with credible evidence generation, rather than firms with a narrow advisory role. Scale-up scarcity may persist because manufacturing licences, quality systems and pharmacovigilance infrastructure raise fixed costs before revenue is predictable. Distribution-led businesses tend to face steadier demand, but margin pressure and inspection risk make compliance discipline a source of resilience rather than a marketing claim. Research-led firms may keep relying on partnerships for clinical, market-access and manufacturing capacity, which points to a cohort shaped by specialist contractors and selective consolidation.
151
Active firms
2026
10
Firms over £5M
reported revenue
65
Incorporated since 2022
newer companies
Key facts
About 6% of the trading cohort reports turnover above £5M (10 of 151 firms) — the rest sits below that revenue band.
43% of the cohort was incorporated since 2022 (65 firms), so a sizeable share is in its first few filing cycles.
Human medicines in the UK sit under MHRA oversight: manufacturers and importers need a manufacturer’s licence, good manufacturing practice compliance and regular site inspections.
Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance.
Pharmaceutical R&D performed by the UK business enterprise sector reached £9.0 billion in 2022, equal to 0.36% of UK GDP and 18% of all UK business R&D.
UK pharmaceutical manufacturing GVA reached £13.7 billion in 2021, the highest value in the 2013–2021 government series.
UK pharmaceutical exports were £25.6 billion in 2023, ranking tenth among comparator countries, while the UK’s commercial clinical-trial recruitment share was 2.6% in 2022.
Top Glasgow pharmaceutical companies
BDD Pharma Ltd
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides contract research and development services for pharmaceutical companies, including oral drug formulation development, biopharmaceutics studies, GMP manufacturing of clinical trial materials,…
Serves pharmaceutical and biotech companies developing oral drug products, especially early-stage programmes needing integrated formulation, GMP manufacturing and Phase I clinical trial support.
Financial Health
StableStable · Hiring · 11% CAGR over 2y
Location
Provides contract development and manufacturing services for pharmaceutical and biotechnology companies, including drug formulation, dose form design, clinical trial supply, and commercial…
Serves B2B pharmaceutical, biotech and self-care health-and-wellness companies worldwide, including innovators and brands in therapies, OTC products, dietary supplements and consumer health.
Location
CEWE PHARMA LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
StableStable
Location
LOGAN PHARMACEUTICALS LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsOperates as an MHRA‑approved pharmaceutical wholesaler and exporter, supplying branded and generic medicines, medical devices, and surgical supplies. Provides procurement, import/export, cold‑chain…
Serves B2B pharmaceutical wholesalers, exporters, hospitals and pharmacies, plus manufacturers seeking distribution routes, across the UK, Europe and wider international markets.
Financial Health
StableStable · -5% CAGR over 3y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsWholesale distributor of pharmaceutical products supplying retail pharmacies, GP surgeries and hospitals. Provides generic medicines, over‑the‑counter products, special order drugs, and licensed…
Serves retail and community pharmacies, GP surgeries and hospitals across the UK and Ireland, with additional pharmaceutical industry clients involved in imports and exports.
Financial Health
HealthyHealthy · Hiring · 15% CAGR over 2y
Location
GARY LEWIS LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsSupplies and distributes pharmaceutical products to pharmacies and healthcare providers. Acts as a wholesale supplier sourcing medicines and healthcare goods, providing ordering, procurement support,…
Serves B2B customers in the pharmaceutical sector, including pharmacies, healthcare retailers and other medicine buyers that need wholesale supply partners for their own customers.
Financial Health
StableStable · -18% CAGR over 2y
Location
AURUM BIOSCIENCES LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops oxygen‑carrying biopharmaceutical compounds for therapeutic and diagnostic use, including treatments for acute ischaemic stroke and imaging of inflammation. Lead candidate ABL‑101 is in…
Targets hospitals, clinicians and healthcare systems involved in acute ischaemic stroke care, inflammation imaging and related indications such as cardiac arrest, oncology, spinal cord injury and…
Financial Health
HealthyHealthy · -11% CAGR over 2y
Location
Tepnel Pharma Services
Trajectory
5y · 2019–NowProvides contract pharmaceutical testing and analytical laboratory services supporting drug development. Services include batch release testing, raw material and microbiology testing, ICH method…
Serves pharmaceutical and biotechnology companies developing or manufacturing medicines, including teams responsible for APIs, investigational products, finished dosage forms, biologics, inhalation,…
Financial Health
Insufficient historyInsufficient history
Location
Torbet Laboratories Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
DistressedDistressed · -13% CAGR over 2y
Location
Catriona Ross LTD
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
HealthyHealthy · 0% CAGR over 1y
Location
Med-link Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
GLYCOLOGIC LIMITED
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops carbohydrate‑based technologies and ingredients for nutrition, over‑the‑counter, and prescription healthcare products. Applies carbohydrate science to create customised solutions for…
Serves B2B customers in the nutrition, OTC healthcare and prescription pharmaceutical sectors, including healthcare product developers and manufacturers, with customers and partners worldwide.
Financial Health
StableStable · -68% CAGR over 4y
Location
Pharma Medicare Ltd
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
WeakWeak
Location
FW MEDICAL LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides market development, distribution, and regulatory support for consumer healthcare products. Acts as a UK sales and marketing partner for healthcare brands, managing retail distribution, key…
Serves B2B healthcare markets: pharmaceutical distributors and healthcare partners seeking consumer health products internationally, plus consumer healthcare brands needing UK retail, regulatory,…
Financial Health
StrongStrong · Growing, Hiring · 11% CAGR over 4y
Location
VAXOL LIMITED
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsMarkets and distributes an ear care spray used to soften and remove earwax, lubricate dry ear canals, and relieve irritation. Provides product information, patient leaflets, FAQs, and distributor…
Serves consumers and patients, including adults and children, seeking ear care products, with routes to market through pharmaceutical and medical device distributors across Europe.
Financial Health
DistressedDistressed
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsResearches and develops pharmaceutical and medical device products intended for healthcare professionals and patients, focusing on treatments and health-related products designed to support patient…
Serves healthcare professionals and patients, addressing a mixed B2B and consumer healthcare market for pharmaceutical and medical device products worldwide.
Financial Health
HealthyHealthy · Growing · 0% CAGR over 2y
Location
GLOBAL CLINICAL TRIAL PARTNERS LTD
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides clinical trial support services, including management of clinical event committees and endpoint adjudication. Offers consultancy on trial design, biostatistics, regulatory strategy, protocol…
Serves B2B organisations running clinical trials, including trial sponsors, pharmaceutical and biotech companies, CROs and academic research teams needing clinical event committee support.
Financial Health
StableStable
Location
Pharmalyfe Limited
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsOperates an online pharmacy supplying aesthetic and cosmetic medical products, including dermal fillers, skin boosters, fat‑dissolving injections, weight‑loss injections, toxins, chemical peels, PDO…
Serves UK-based aesthetic practitioners, private clinics and training academies, targeting professional buyers in cosmetic aesthetics, skin treatment and private healthcare settings rather than…
Financial Health
HealthyHealthy · 0% CAGR over 3y
Location
Creation Of Selfcare Ltd
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
HealthyHealthy
Location
TARGET HEALTHCARE LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures and supplies unlicensed “specials” medicines and distributes generic and branded pharmaceuticals. Provides wholesale supply to pharmacies, hospitals and healthcare providers, including…
Serves B2B healthcare buyers including pharmacies, hospitals, dispensing doctors, pharmaceutical wholesalers and buying groups in the UK and worldwide, with export customers across over 100 countries…
Financial Health
HealthyHealthy · Hiring · 32% CAGR over 4y
Location
Wallace Pharmaceuticals Ltd
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsManufactures and develops pharmaceutical and biotechnology products. Produces prescription medicines and over‑the‑counter treatments across therapeutic areas including antibiotics, cardiovascular,…
Serves healthcare providers, healthcare professionals and patients internationally across prescription and over-the-counter therapeutic areas.
Financial Health
StrongStrong · Growing, Hiring · 11% CAGR over 1y
Location
Ethigen
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsSupplies and distributes pharmaceutical products to pharmacies, GP surgeries and hospitals. Provides generic medicines, over‑the‑counter products and special order drugs, with procurement, import and…
Serves retail and community pharmacies, GP surgeries and hospitals, plus other pharmaceutical industry clients across the UK and Ireland, with import/export customers in Europe and Asia.
Financial Health
HealthyHealthy · Profitable, Hiring · 15% CAGR over 2y
Location
Develops and manufactures specialty biopharmaceutical medicines, focusing on reproductive medicine and maternal health as well as treatments for gastroenterology and urology conditions. Conducts…
Serves healthcare professionals, healthcare systems and patients/families needing treatments in reproductive medicine, maternal health, gastroenterology, urology and uro-oncology, with global…
Location
Kee Logic Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
Aver Generics Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsSupplies pharmaceuticals to pharmacies and retailers, including generic medicines, parallel‑imported branded drugs, controlled drugs, and over‑the‑counter products. Also distributes dispensing…
Serves independent and retail pharmacies across Scotland and the wider UK, targeting pharmacy owners, dispensers and purchasing teams that buy medicines and pharmacy supplies for resale to patients.
Financial Health
StrongStrong · Growing, Hiring · 18% CAGR over 5y
Location
Confidence Plus Ltd
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
DistressedDistressed
Location
JOHN AND JOHNSON LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and manufactures pharmaceutical medicines and medical devices. Researches and produces treatments in areas including oncology, immunology, neuroscience and cardiopulmonary disease, and…
Serves healthcare providers, health systems and patients worldwide across oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery and vision markets.
Financial Health
HealthyHealthy · -13% CAGR over 2y
Location
DEARS STOCKBRIDGE LIMITED
Trajectory
1y · 2024–NowFinancial Health
Insufficient historyInsufficient history
Location
MUNRO HEALTHCARE GROUP LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsOperates a pharmaceutical wholesaler supplying medicines and healthcare products. Manages procurement, distribution and supply availability for pharmacy and healthcare customers, and undertakes…
Serves B2B customers and partners across the pharmaceutical market, including pharmacies, wholesalers and healthcare organisations requiring reliable pharmaceutical supply relationships.
Financial Health
HealthyHealthy · Hiring · 12% CAGR over 2y
Location
Provides logistics and distribution services for the healthcare sector, including warehousing, stock management and delivery of pharmaceuticals, renal dialysis fluids, medical and surgical devices,…
Serves B2B customers across the UK healthcare market, including healthcare providers, NHS and private hospitals, pharmaceutical manufacturers, and suppliers of medical, surgical and high-value…
Location
CLYDE BIOSCIENCES LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides contract research services using human cardiomyocyte assays to assess cardiac safety and efficacy of drug candidates. Uses the CellOPTIQ platform to measure voltage, calcium, and…
Sells to pharmaceutical companies, biotech firms and regulatory agencies needing cardiac safety and efficacy testing for drug development. Targets R&D, safety pharmacology and toxicology teams…
Financial Health
StableStable · Hiring · 11% CAGR over 4y
Location
BIOCLAVIS LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides transcriptomic and genomic analysis services using the TempO‑Seq platform for pharmaceutical, academic and clinical research. Supports drug discovery, biomarker identification and companion…
Serves pharmaceutical companies, academic research groups and clinical researchers working on drug discovery, companion diagnostics, biomarker development and molecular profiling.
Financial Health
StableStable · -10% CAGR over 4y
Location
Unlock all 151 leads
Showing 32 of 151 — +119 more with verified decision-maker contacts, live data, and CRM sync.
How Glasgow pharmaceutical companies work and how to sell to them
What they do
Revenue usually comes from regulated product supply, contracted technical work and specialist services around medicines. Glasgow pharmaceutical firms may sell licensed medicines into wholesale or public-sector channels, earn margin on distribution, charge per batch for manufacturing or assembly, or bill retainers and project fees for regulatory, quality, pharmacovigilance and market-access support. Research-led operators tend to rely more on milestones, service income and partnerships before a medicine is commercial. Pricing is shaped less by seat counts than by batch complexity, validation requirements, licence scope, storage conditions and the amount of accountable documentation needed for audit.
Who they sell to
Typical customers include medicine developers, wholesalers, hospital-facing suppliers, pharmacy channels, public-sector health buyers and larger pharmaceutical groups needing local technical capacity. Buying committees tend to include quality directors, responsible persons, qualified persons, regulatory affairs leads, supply-chain managers, medical teams and procurement. Self-serve purchasing is uncommon for core activity; most deals move through direct relationships, framework access, tenders, distributor agreements or referral-led specialist contracting. Smaller advisory or documentation projects may close faster, while manufacturing, import, distribution and market-access work usually carries longer diligence, because the buyer is taking on regulatory and supply-continuity exposure.
What they buy
Most pharmaceutical firms tend to spend on systems and services that make regulated work repeatable: quality management software, document control, training records, validation support, pharmacovigilance tooling, batch-release workflows, laboratory information management, ERP, inventory control and audit management. Distribution-led operators also buy cold-chain logistics, warehousing, packaging, serialisation, transport monitoring and insurance. Research-led firms often need clinical operations support, biostatistics, health-economics evidence, regulatory writing, intellectual property advice and market-access consultancy. Across the cohort, recruitment is a recurring need for quality, regulatory affairs, technical operations and commercial roles, while finance, legal and cybersecurity buying tends to follow customer scrutiny or licence-related change.
Why and how to sell to them
Pharmaceutical buyers tend to evaluate vendors when inspection pressure, licence changes, new facilities, NHS-facing opportunities or expansion into import and wholesale activity expose gaps in process control. Other triggers include a new quality leader, a move from advisory work into operational supply, a partnership with a medicine developer, or customer due diligence that asks for clearer audit trails. Outbound messages usually land better when they are specific to regulated operations: reducing batch-release administration, improving traceability, preparing for MHRA inspection, evidencing GDP or GMP routines, or lowering the cost of maintaining validated systems without adding avoidable manual work.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Glasgow
Related directories
Frequently asked questions
How many pharmaceutical companies are there in the Glasgow?↓
What counts as a pharmaceutical company in this list?↓
Which are the largest pharmaceutical companies in the Glasgow?↓
What do pharmaceutical companies in the Glasgow actually do?↓
How does Glasgow pharmaceutical compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical pharmaceutical companies in the Glasgow?↓
Are these mostly new or established pharmaceutical companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 151 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.